C57BL/6NCya-Fmr1em1/Cya
Common Name
Fmr1-KO
Product ID
S-KO-02093
Backgroud
C57BL/6NCya
Strain ID
KOCMP-14265-Fmr1-B6N-VA
Status
When using this mouse strain in a publication, please cite “Fmr1-KO Mouse (Catalog S-KO-02093) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
Basic Information
Strain Name
Fmr1-KO
Strain ID
KOCMP-14265-Fmr1-B6N-VA
Gene Name
Product ID
S-KO-02093
Gene Alias
FMRP, Fmr-1
Background
C57BL/6NCya
NCBI ID
Modification
Conventional knockout
Chromosome
Chr X
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000088546
NCBI RefSeq
NM_008031
Target Region
Exon 2~5
Size of Effective Region
~7.4 kb
Overview of Gene Research
Fmr1, or Fragile X Messenger Ribonucleoprotein 1, is a gene that plays a crucial role in regulating mRNA transport and translation of target mRNAs at the synapse [4]. It is involved in three different syndromes: fragile X syndrome (FXS), premature ovarian insufficiency (POI), and fragile X-associated tremor/ataxia syndrome (FXTAS) [4]. FXS is caused by a CGG-repeat expansion above 200 units in the Fmr1 gene, leading to the absence of Fmr1 mRNA and protein, representing a loss-of-function disorder [4]. POI and FXTAS are associated with an expanded repeat between 50-200 CGGs and increased Fmr1 mRNA levels, with FXTAS potentially being a toxic RNA gain-of-function effect [4].
Fmr1 mutations, such as the rare missense mutation (c.413G>A), can also cause FXS-like phenotypes without the typical CGG-repeat expansion [1]. In FXS, aberrant alternative splicing of Fmr1 mRNA occurs, generating the FMR1-217 RNA isoform, and antisense oligonucleotide treatment can rescue full-length Fmr1 RNA and restore FMRP (the protein encoded by Fmr1) [2]. Fmr1 premutation carriers are at risk of developing FXTAS and FXPOI, and recent metabolic studies in these carriers may provide insights into potential biomarkers and therapeutic pathways [3].
In conclusion, Fmr1 is essential for normal synaptic function, and its dysregulation through mutations or repeat expansions is associated with multiple disorders including FXS, POI, and FXTAS. Studies on Fmr1-related disorders help understand the gene's role in these diseases, potentially leading to the development of new therapeutic strategies for these conditions [1,2,3,4].
References:
1. Sitzmann, Adam F, Hagelstrom, Robert T, Tassone, Flora, Hagerman, Randi J, Butler, Merlin G. 2017. Rare FMR1 gene mutations causing fragile X syndrome: A review. In American journal of medical genetics. Part A, 176, 11-18. doi:10.1002/ajmg.a.38504. https://pubmed.ncbi.nlm.nih.gov/29178241/
2. Shah, Sneha, Sharp, Kevin J, Raju Ponny, Sithara, Berry-Kravis, Elizabeth, Richter, Joel D. 2023. Antisense oligonucleotide rescue of CGG expansion-dependent FMR1 mis-splicing in fragile X syndrome restores FMRP. In Proceedings of the National Academy of Sciences of the United States of America, 120, e2302534120. doi:10.1073/pnas.2302534120. https://pubmed.ncbi.nlm.nih.gov/37364131/
3. Cao, Yiqu, Peng, Yun, Kong, Ha Eun, Allen, Emily G, Jin, Peng. 2020. Metabolic Alterations in FMR1 Premutation Carriers. In Frontiers in molecular biosciences, 7, 571092. doi:10.3389/fmolb.2020.571092. https://pubmed.ncbi.nlm.nih.gov/33195417/
4. Oostra, Ben A, Willemsen, Rob. 2009. FMR1: a gene with three faces. In Biochimica et biophysica acta, 1790, 467-77. doi:10.1016/j.bbagen.2009.02.007. https://pubmed.ncbi.nlm.nih.gov/19233246/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
